Group One Trading’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Group One Trading’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279	Buy	+143	New	+$292	﹤0.01%	7357
2026 Q1	–	Sell	-3,963	Closed	-$13.3K	–	8124
2025 Q4	$15.8K	Buy	+3,963	New	+$17.5K	﹤0.01%	6536
2022 Q4	–	Sell	-1,974	Closed	-$8K	–	7627
2022 Q3	$8K	Sell	1,974 -23,584	-92%	-$179K	﹤0.01%	6629
2022 Q2	$289K	Buy	+25,558	New	+$306K	﹤0.01%	3940
2021 Q3	–	Sell	-156	Closed	-$11.3K	–	8441
2021 Q2	$13K	Buy	+156	New	+$10.3K	﹤0.01%	7407

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading's NBP Position: Q2 2026 in Review

Group One Trading opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 143 shares worth $279. The stake represents ﹤0.01% of the portfolio and ranks #7357 among its holdings. This is a return to the name: Group One Trading previously reported a position in NBP as recently as Q4 2025.

Group One Trading first reported a position in NBP in Q2 2021 and has held it in 5 quarters since. The position peaked at $289K in Q2 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Group One Trading held 143 shares of NovaBridge Biosciences American Depositary Shares worth $279 as of Q2 2026.
NovaBridge Biosciences American Depositary Shares was a new Group One Trading position in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7357 holding.
Group One Trading first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and has held it in 5 quarters since.
Group One Trading's NovaBridge Biosciences American Depositary Shares position peaked at $289K in Q2 2022.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.